US FDA to step up inspections of drug manufacturing facilities in India
The US drug regulator is set to increase inspections at Indian drug manufacturing facilities in 2024 amid growing concerns over drug quality, a top Food and Drug Administration official told Reuters.
POPULAR POSTS
Earthquakes and emissions undermine the idea of carbon storage in Texas
December 17, 2024
Rescuers search for cyclone survivors in devastated Mayotte
December 17, 2024
“Gilmore Girls” airs for a second season on Hulu
December 17, 2024
LIVE STREAM
